Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS

Author： Hultquist Judd F   Harris Reuben S  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.4, Iss.6, 2009-11, pp. : 605-619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiidiotype-Derived Killer Peptides As New Potential Tools to Combat HIV-1 and AIDS-Related Opportunistic Pathogens

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 4, 2007-10 ,pp. : 263-272

Bentham Science Publishers

Access to resources Recommend Favorite

Russia has received its first grants approval from the Global Fund to Fight AIDS, Tuberculosis and Malaria to help combat HIV/AIDS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 440, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Strategies for Inhibiting Function of HIV-1 Accessory Proteins: A Necessary Route to AIDS Therapy?

By  

Current Medicinal Chemistry, Vol. 16, Iss. 3, 2009-01 ,pp. : 267-286

Bentham Science Publishers

Access to resources Recommend Favorite

Etravirine for the treatment of HIV/AIDS

By Schrijvers Rik  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1087-1096

Informa Healthcare

Access to resources Recommend Favorite

Nanomedicines as Therapeutics in HIV-AIDS

By  

Pharmaceutical Nanotechnology, Vol. 4, Iss. 4, 2016-12 ,pp. : 255-266

Bentham Science Publishers

Access to resources Recommend Favorite